Oncternal Therapeutics, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-12. The offering totals $78.2M, of which $48.5M was reported sold. Industry: Biotechnology.
Showing 25 of 35 people.
| Name | Role | Location |
|---|---|---|
| Michael G Carter, M.D., Ch.B., F.R.C.P. | Director | Memphis, TN |
| J. Kenneth Glass | Director | Memphis, TN |
| Marc S Hanover | Director | Memphis, TN |
| J. R Hyde, III | Director | Memphis, TN |
| Garry A Neil, M.D. | Director | Memphis, TN |
| Kenneth S Robinson, M.D., M.Div. | Director | Memphis, TN |
| Robert J Wills, Ph.D. | Director | Memphis, TN |
| Henry P Doggrell | Executive Officer | Memphis, TN |
| Marc S Hanover | Executive Officer | Memphis, TN |
| Jason T Shackelford | Executive Officer | Memphis, TN |
| Robert J Wills, Ph.D. | Executive Officer | Memphis, TN |
| Diane C Young, M.D. | Executive Officer | Memphis, TN |
| William R LaRue | Director | San Diego, CA |
| Xin R Nakanishi, Ph.D. | Director | San Diego, CA |
| Charles R Theuer | Director | San Diego, CA |
| Robert R Wills, Ph.D. | Director | San Diego, CA |
| Man R Cho | Director | San Diego, CA |
| James B Breitmeyer, M.D., Ph.D. | Director | San Diego, CA |
| James B Breitmeyer, M.D., Ph.D. | Executive Officer | San Diego, CA |
| Igor B Bilinsky, Ph.D. | Executive Officer | San Diego, CA |
| Frank B Hsu, M.D. | Executive Officer | San Diego, CA |
| Gunnar F Kaufmann | Executive Officer | San Diego, CA |
| Michael G Carter, M.D., ChB, FRCP | Director | San Diego, CA |
| Daniel G Kisner, M.D. | Director | San Diego, CA |
| Hazel M Aker | Executive Officer | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2020-12-22 | D | $6.5M | $6.5M |
| 2020-11-24 | D | $1.7M | $1.7M |
| 2020-09-09 | D | $383K | $383K |
| 2020-08-03 | D | $3.5M | $3.5M |
| 2020-06-03 | D | $2.8M | $2.8M |
| 2014-11-24 | D | $43.4M | $43.4M |
| 2014-03-07 | D/A | $21.3M | $21.3M |
| 2014-03-06 | D | $21.3M | $21.3M |